MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA
出版年份 2018 全文链接
标题
MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-08-14
DOI
10.3389/fphar.2018.00856
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cutaneous melanoma: From pathogenesis to therapy (Review)
- (2018) Giulia Leonardi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers
- (2018) Casey L. Ross et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
- (2018) Lena Gorgannezhad et al. LAB ON A CHIP
- Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers?
- (2018) Mattia Branca et al. MELANOMA RESEARCH
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
- (2017) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma
- (2017) Lan Yang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review
- (2017) Alicia Brunssen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
- (2017) Giuseppe V. Masucci et al. Journal of Translational Medicine
- Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers
- (2017) Robin Veenstra et al. LABORATORY INVESTIGATION
- NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanoma
- (2017) Claudio Guarneri et al. ONCOLOGY REPORTS
- Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis
- (2017) Peng Chen et al. OncoTargets and Therapy
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications
- (2017) Benoit Busser et al. Biomed Research International
- Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways
- (2017) Sha Liu et al. Cancer Medicine
- Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review
- (2016) Francesco Spagnolo et al. CANCER TREATMENT REVIEWS
- Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
- (2016) Max Schreuer et al. Journal of Translational Medicine
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
- (2016) Silvana Sandri et al. PHARMACOLOGICAL RESEARCH
- The genomic landscape of cutaneous melanoma
- (2016) Tongwu Zhang et al. Pigment Cell & Melanoma Research
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer
- (2016) Luca Falzone et al. Oncotarget
- Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
- (2015) A. Santiago-Walker et al. CLINICAL CANCER RESEARCH
- Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways
- (2015) Yu-Jen Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular galectin-3 induces MMP9 expression by activating p38 MAPK pathway via lysosome-associated membrane protein-1 (LAMP1)
- (2015) Manohar C. Dange et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model
- (2015) Hui Shi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
- (2015) Elin S. Gray et al. Oncotarget
- Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation
- (2015) Veronique Mathieu et al. Oncotarget
- Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
- (2014) M. F. Sanmamed et al. CLINICAL CHEMISTRY
- β-Elemene inhibits the metastasis of B16F10 melanoma cells by downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9
- (2014) Hong Shi et al. MELANOMA RESEARCH
- RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo
- (2013) Zhao-Yong Tang et al. CELL BIOLOGY INTERNATIONAL
- Molecular networks in melanoma invasion and metastasis
- (2013) Ewa Aladowicz et al. Future Oncology
- Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma
- (2013) Paolo A. Ascierto et al. JOURNAL OF CLINICAL ONCOLOGY
- Extracellular Matrix Degradation and Remodeling in Development and Disease
- (2011) P. Lu et al. Cold Spring Harbor Perspectives in Biology
- Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness
- (2010) Srinivas Saladi et al. Molecular Cancer
- Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells
- (2009) Gabriel M. Gordon et al. JOURNAL OF CELLULAR PHYSIOLOGY
- BRAF(V600E) mutation and the biology of papillary thyroid cancer
- (2008) F Frasca et al. ENDOCRINE-RELATED CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now